wk10

rewrite and use new references:

Shadow Health Assignment: Synopsis, Reflection and Rationale for Drug Therapy

Synopsis

The Focused Exam: Hypertension in Shadow Health and the Antihypertensives Concept Lab provided an opportunity to apply the principles of a pharmacotherapeutic approach to the treatment of hypertension and type 2 diabetes mellitus (T2DM). The simulated patient, who is a 38-year-old Indian American male, Mr. Arun Patel, came to a check-up with a medical history of generalized anxiety disorder, hypertension, and T2DM. Changes in his lifestyle recently, such as weight gain, diet, and decreased physical activity, are factors that led to suboptimal glycemic and blood pressure regulation. Mr. Patel’s vital signs indicated a blood pressure of 146/94 mmHg and a heart rate of 75 beats per minute (bpm). The laboratory results showed unstable glycemic levels, with a fasting glucose of 210 mg/dL and an A1C of 9.3%, indicating that the patient was progressing through the disease and had not returned to a level of 7.5% as six months ago. The fact that his symptoms of fatigue, weight gain, and polyuria also supported an increase in metabolic control.

The module enhanced knowledge of the physiological determinants of blood pressure, including cardiac output, peripheral vascular resistance, and blood volume. The pathophysiology of hypertension has been investigated as a complicated interaction among the sympathetic nervous system, renal dysfunction, and the renin-angiotensin-aldosterone system (RAAS). The review of pharmacologic interventions was based on their mechanisms of action and therapeutic effects. Thiazide diuretics lower blood volume, calcium channel blockers and ACE inhibitors lower peripheral resistance, and beta-blockers lower cardiac output. Two combination therapies were prescribed to manage the comorbid conditions in Mr. Patel, and they were lisinopril/hydrochlorothiazide 10 mg/12.5 mg and glipizide/metformin 2.5 mg/500 mg, both twice daily with meals, all within 30 days in accordance with the national guidelines. The dual therapy aimed at addressing high blood pressure and hyperglycemia, which is in line with the evidence-based guidelines in patients with diabetes and hypertension

Reflection: What I Learned.

The Shadow Health experience helped me improve my understanding of the correlation between pathophysiology and pharmacologic treatment of long-term diseases, such as diabetes and hypertension. It emphasized the interaction of hypertension with T2DM and its prevalence in people exposed to heart diseases. I learned that the pharmacologic management of diabetes must involve not only blood pressure but also glucose level, renal, and cardiovascular long-term effects (Hezam et al., 2024). I also obtained an understanding of the role played by pharmacodynamics and pharmacokinetics in the selection of drugs. As an illustration, thiazide diuretics are effective in reducing blood pressure by stimulating sodium and water secretion, and ACE inhibitors also offer a renal protective effect by lowering the glomerular filtration pressure, which is essential for patients with diabetes. The mechanisms enabled me to relate theoretical pharmacology with clinical reasoning (Ernstmeyer & Christman, 2023).

My experience with the assignment in learning to prescribe medications.

This assignment helped me to gain skills in how to use prescribing guidelines and to make rational decisions regarding the choice of drugs for patients with comorbid hypertension and diabetes. The ACE inhibitors or ARBs are the first-line antihypertensive agents of diabetic patients according to the guidelines of the American Diabetes Association (ADA, 2025) and American College of Cardiology/American Heart Association (ACC/AHA, 2025) due to their ability to lower cardiovascular morbidity and slow the progression of diabetic nephropathy (Jones et al., 2025). I was able to practice safe and effective prescribing through the simulation, including the correct dosage, frequency, and monitoring parameters. It emphasized the need to evaluate compliance with medications, the reality of side effects, and the necessity of reinforcing lifestyle changes and pharmacotherapy. The virtual environment also allowed me to train patients in diet, physical activity, and blood pressure and glucose monitoring.

Rationale for Drug Therapy

a. Lisinopril/Hydrochlorothiazide+

Lisinopril (an ACE inhibitor) was chosen in combination with hydrochlorothiazide (a thiazide diuretic) to treat hypertension in Mr. Patel. Lisinopril interferes with the angiotensin I to angiotensin II conversion, which causes vasoconstriction and aldosterone secretion, thereby decreasing blood pressure and protecting the kidney (Singh et al., 2025). This effect is complementary and is achieved by reducing the plasma volume and peripheral vascular resistance with the help of hydrochlorothiazide. The 2025 ACC/AHA Hypertension Guidelines also recommend a combination of an ACE inhibitor and a thiazide diuretic in patients whose blood pressure remains above target, even with monotherapy. Additionally, ACE inhibitors are particularly beneficial in patients with diabetes, as they delay the onset of nephropathy and reduce cardiovascular events (Jones et al., 2025).

b. Glipizide/Metformin

In the case of Mr. Patel’s uncontrolled T2DM, a combination of glyburide and metformin was ordered. Metformin is a biguanide that reduces the production and synthesis of hepatic glucose in the liver and increases peripheral insulin sensitivity in the body. Glipizide is a sulfonylurea that triggers pancreatic beta cells to produce insulin (American Diabetes Association, 2025). The ADA Standards of Care (2025) recommend that metformin should be the initial treatment for T2DM, and a second oral agent should be added to the therapy if glycemic goals have not been achieved within three months. Given that Mr. Patel has an A1C level of 9.3%, combination therapy is reasonable to have quicker glycemic control and decrease the chances of microvascular complications. Hypoglycemia and renal function should be monitored regularly when sulfonylureas and metformin are used simultaneously.

Conclusion

The Shadow Health experiences combined pathophysiological knowledge with clinical pharmacology to control complex comorbidities. I learned how to customize therapy according to nationally based, evidence-based guidelines and patient-specific variables, such as lifestyle, comorbidities, and laboratory results. The activity boosted my self-confidence in prescribing antihypertensive and antidiabetic drugs. It reminded me of the importance of holistic patient education and follow-up in achieving optimal health outcomes.

References

American Diabetes Association. (2025). Standards of medical care in diabetesâ€”2025. Diabetes Care, 48(Supplement 1), S1-S167. https://professional.diabetes.org/standards-of-care

Ernstmeyer K, Christman E, editors. Open Resources for Nursing (Open RN); Nursing Pharmacology [Internet]. 2nd edition. Eau Claire (WI): Chippewa Valley Technical College; 2023. Chapter 1 Pharmacokinetics & Pharmacodynamics. https://www.ncbi.nlm.nih.gov/books/NBK595006/

Hezam AAM, Shaghdar HBM, Chen L. The connection between hypertension and diabetes and their role in heart and kidney disease development. J Res Med Sci. 2024 Apr 29;29:22. PMID: 38855561; PMCID: PMC11162087. https://doi.org/10.4103/jrms.jrms_470_23

Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., … & Williamson, J. D. (2025). 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 152(11), e114-e218. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001356

Singh B, Cusick AS, Goyal A, et al. ACE Inhibitors. [Updated 2025 May 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430896/

Are you struggling to create a sound and comprehensive nursing paper? Do you feel overwhelmed with the amount of time and effort it takes to write a good piece? Are you looking for the best nursing paper writing service that can assist you in your nursing paper needs? Look no further than our skilled team of professional writers who specialize in providing high-quality papers with the best nursing paper writing services reviews. Make your order at nursingpaperhelp.com